Why is it difficult for Fat Donglai to solve Yonghui's questions
Fat Donglai, who was once praised by Lei Jun as “the magic presence of China's retail industry,” has been a bit busy lately. Following the launch of targeted support for*ST Bugao (002251.SZ) in December of last year, Fat Donglai recently took another step to help Yonghui Supermarket (601933.SZ), a leading fresh food supermarket. As soon as news broke that the founder of Fat Donglai visited Yonghui Supermarket's Zhengzhou store on May 8, Yonghui Supermarket immediately reaped a rise and fall, increasing its market value by 2.2 billion yuan. But in reality, Fat Donglai, who set off the secondary market, is only a regional retailer in the far corner of Henan Province. Revenue just broke 10 billion dollars in 2023; Yonghui Supermarket is the industry
April 2024 Production and Sales Data Report
Demand for memory chips picked up, GigaYi innovated both revenue and profit growth in Q1 | Financial News
Q1 net profit increased 36.45% year over year, surpassing the full year of last year.
Spending 10 billion dollars, Changdian Technology's China Resources Department is expected to “kill two birds with one stone”
Yellow Finch is in the back
The three-quarter report on AI concept stocks continues to be divided: Zhongke Shuguang's net net increase of 20% year-on-year, Kunlun Wanwei turned a loss, and Tom Cat's net profit fell by 87% | Financial News
Zhongke Shuguang's performance in the fields of innovation and AI grew steadily, Kunlun World Wide's overseas business revenue increased, and Tom Cat's performance declined due to the weakening global economy and the launch of no new products.
Huahai Pharmaceutical's refinancing bets on 100 tons of COVID-19 drugs: disputes over economic benefits still exist
In the context of tightening refinancing, the rationality and necessity of refinancing for A-share companies has received widespread attention from the market. Recently, Huahai Pharmaceutical (600521.SH) updated the refinancing inquiry response materials. Among them, the issue of the rationality of estimating the economic benefits of the production expansion plan attracted the attention of the regulatory authorities. According to the application materials, Huahai Pharmaceutical plans to raise 1,560 billion yuan to invest in the construction of “digital intelligent manufacturing of formulations”, “multi-functional production platform for specialty APIs such as antiviruses” projects, and supplementary liquidity. Among them, the “Multifunctional Production Platform for Antiviral and Other Special APIs” project involves “an annual output of 100 tons
China's National Medical Products Administration In Late December Met With Several Chinese Drugmakers Including Zhejiang Huahai Pharmaceutical And CSPC Pharmaceutical Group To Discuss Preparations Needed To Make A Generic Version Of Paxlovid
China's National Medical Products Administration In Late December Met With Several Chinese Drugmakers Including Zhejiang Huahai Pharmaceutical And CSPC Pharmaceutical Group To Discuss Preparations Nee
Changjiang Securities: nuclear power examination and approval to accelerate the judgment of the realization of power and coal management and control has been strengthened by the policy
Zhitong Financial APP learned that Changjiang Securities issued a research report saying that the executive meeting of the State Council proposed to fully release advanced coal production capacity, guide coal prices to operate within a reasonable range, and approve three new nuclear power unit projects that have been comprehensively evaluated and reviewed and incorporated into national planning. The expectation of accelerated approval of nuclear power projects has been fulfilled, and the relevant listed companies are expected to take the lead to benefit from the positive development of the industry; the market and planning are two sets of means in parallel, it is expected to jointly promote coal prices to return to the rational level in the two aspects of coal supply and demand and price guidance, and is optimistic about the marginal improvement of thermal power profitability. Event: on April 20, the executive meeting of the State Council decided on energy.
Beishui Jiacang Meituan HK $700 million, increasing its position in Tencent for the second day in a row; Nanshui bought shares in Shaanxi Coal Industry and Longji
Southbound Capital bought a net HK $3.16 billion today, while Wuxi Biologics and Tencent received a net purchase of HK $591 million and HK $391 million respectively. Northbound funds bought a net 6.385 billion yuan, while Shaanxi Coal Industry, Longji shares, and Zijin Mining Group received a net purchase of 534 million yuan, 450 million yuan, and 347 million yuan, respectively.
CStone Pharma Grants Jiangsu Hengrui Rights to Investigational Cancer Drug in Greater China
07:49 PM EST, 11/21/2021 (MT Newswires) -- CStone Pharmaceuticals (HKG:2616) granted Jiangsu Hengrui Pharmaceuticals (SHA:600276) an exclusive license to its CS1002 antibody, which is under clinical
Value Partners Group Says China Is a Very Attractive Story
Value Partners Group is moving quite a lot of money into normal manufaturing companies while thinking that China will continue to emphasize manufacturing as a key engine of economic.
Market Chatter: Chinese Solar Panel Maker LONGi Eyes Global Expansion
06:14 PM EST, 11/11/2021 (MT Newswires) -- LONGi Green Energy Technology (SHA:601012) is considering expanding outside China to take advantage of countries' transition into green energy, media report
All of a sudden! Northbound funds sold on a large scale, what happened?
The bottom of the two cities rebounded in the afternoon, rising stocks increased significantly, and the three major indexes closed with a long shadow. Medicine plate pulled up in the afternoon, Watson biology, Heng Rui medicine once impact the limit; semiconductor chips, real estate, photovoltaic and other plates have been pulled up. On the whole, individual stocks generally rose, with more than 2700 shares floating red, and the turnover on the Shanghai and Shenzhen stock markets exceeded trillion yuan for the 14th trading day in a row. Gem new shares Longhua new materials closed up 146%, Qiang Rui technology closed up 88%, all triggered a second temporary stop in intraday trading. By the close, the Prev index was down 0.41%, the Shenzhen index was down 0.38%, and the gem index was down 0.3%. Northbound funds are sold net throughout the day.
BRIEF-LONGi Green Energy Clarifies Media Reports Over Products Export To The U.S.
Nov 3 (Reuters) - LONGi Green Energy Technology Co Ltd601012.SS :* SAYS U.S. CUSTOMS HAS WITHHOLD CO AND UNIT'S 40.31 MW OF MODULE PRODUCTS EXPORTED TO THE U.S. UNDER WITHHOLD RELEASE ORDER (WRO), CL
LONGi Green Energy’s Q3 Profit Grows 14% as Revenue Beats Forecasts; Shares Jump 4%
01:20 AM EDT, 11/01/2021 (MT Newswires) -- LONGi Green Energy Technology (SHA:601012) posted a double-digit jump in profit and revenue in the third quarter of the year, beating market estimates. The
Chinese Stocks End Higher as Energy Companies Gain -- Market Talk
0724 GMT - Chinese stocks ended higher, with energy companies rising amid high energy-commodity prices while consumer-related companies fell. The Shanghai Composite Index rose 0.8% to end at 360
Chinese Stocks Rise as Renewable Energy, Coal Companies Gain -- Market Talk
0200 GMT - Chinese stocks rise, driven by gains in renewable-energy companies and coal producers. The benchmark Shanghai Composite Index is 0.4% higher at 3581.27 and Shenzhen Composite Index ad
Chinese Shares End Higher; Coal Producers, Renewable-Energy Companies Gain -- Market Talk
0720 GMT - Chinese shares closed higher with coal and renewable-energy companies rising. Renewable-energy companies are facing tailwinds from continued policy support as China seeks to decarboni
Shunfeng Eyes $64 Million Sale of Two Power Plants for Debt Payments; Shares Jump 3%
02:25 AM EDT, 10/07/2021 (MT Newswires) -- Shunfeng International Clean Energy (HKG:1165) is looking to sell two solar power plants to China National Nuclear Power (SHA:601985) for 414.7 million yuan
Global Semiconductor Shortage to Ease Through Q4, IDC Says
02:03 AM EDT, 09/23/2021 (MT Newswires) -- The global shortage of semiconductors will continue easing through the fourth quarter of the year before reaching a potential overcapacity by 2023, market r